Article Review :Klebsiella Pneumonia: Epidemiology, Virulence Factors and Treatment | ||
| Journal of University of Anbar for Pure Science | ||
| Article 13, Volume 14, Issue 2, August 2020, Pages 5-10 PDF (1.99 M) | ||
| Document Type: Review Paper | ||
| DOI: 10.37652/juaps.2022.172338 | ||
| Authors | ||
| Saif T. Jasim* 1; Ahmed Sami Farhan2 | ||
| 1Department of Al-Qaim Education, General Directorate of Education in Anbar,Ministry of Education, Al-Qaim, Anbar, Iraq | ||
| 2Department of Biology , College of Science, University of Anbar , Anbar, Iraq | ||
| Abstract | ||
| Klebsiella pneumoniae is a rare cause, excluding alcoholics, of community-acquired pneumonia. Klebsiella can resemble lung tuberculosis because it occurs with hemoptysis and lesions of the lumen. K. Pneumoniae is an infection hard to handle because of the organism's thickened capsule. Klebsiella is best handled with cephalosporins, quinolones or carbapenems of the third and fourth century. In lung inflammation, monotherapy is just as effective as combination therapy because newer agents are used. Older agents with less Klebsiella involvement were used for successful treatment in the past. Initially, the patient that we attended was believed to have pulmonary tuberculosis and the recommended medication was ceftriaxone monotherapy until it was discovered to be pneumococcal disease. The patient was initially treated with injection, then orally for 3 weeks. The purpose of this article is to address this type of bacteria, its epidemiology, virulence factors and treatment methods, due to its widespread spread within the country, which causes many respiratory diseases and can share with other pathogens such as viruses, particularly the Corona virus, which can inevitably cause death in a particular individual. | ||
| Keywords | ||
| Klebsiella pneumonia; taxonomy; Epidemiology; virulence factors; Capsular Polysaccharides | ||
| References | ||
|
[1] Brooks, G.F.,Butel, J.S., Carroll,K.C. and Morse, S.A .(2007). Jawetz , Melnick, and Medical microbiology. 24th ed. McGraw-Hill.p:254-255. New York.
[2] Vuotto, C., Longo, F., Pia,B.M, Donelli, G. and Varaldo, P.E.(2014). Antibiotic Resistance Related to Biofilm Formation in Klebsiella pneumonia. Pathogens: 3: 743-758.
[3] Reid, G., Charbonneau-Smith, R., Lam, D., Kang, Y.S., Lacerte, M., and Hayes, K.C.(1992). Bacterial biofilm formation in the urinary bladder of spinal cord injured patients. Paraplegia, 30(10):711–717.
[4] Yang, D. and Zhang,Z.(2008). Biofilm-forming Klebsiella pneumoniae strains have greater likelihood of producing extended-spectrum beta-lactamases. J. Hosp. Infect. 68: 369–371.
[5] Ryan, K.J.,and Ray, C.G. (2004). Sherris Medical Microbiology(4th ed.). McGraw Hill.p:370. New York.
[6] Brisse,S.,Grimont.F. and Grimont,P.A.D.(2006). The Genus Klebsiella. Prokaryotes, 6:159–196.
[7] Rasmussen, B. A., and Bush,K. (1997). Carbapenem-hydrolyzing B lactamases. Antimicrob. Agents Chemother. 41:223–232.
[8] Grimont,P.A.D. and Grimont, F. (2005). Genus Klebsiella. In: Bergey’s manual of systematic bacteriology . 2nd ed . Vol. (2). Springer. USA.
[9] Tsai, S.S., Huang,J.C., Chen,S.T., Sun,T.H, Wang,C.C., Lin,S.F.,N Hsu,B.R.S, Lin,J.D.,Huang,S.U. and Huang,Y.Y.( 2010). Characteristics of Klebsiella pneumoniae Bacteremia in Community-acquired and Nosocomial Infections in Diabetic Patients. Chang Gung Med J. 33(5): 532-539.
[10] Esposito, E.P, Cervoni, M, Bernardo, M, Crivaro, V, Cuccurullo, S, Imperi, F, and Zarrilli, R.(2019). Molecular Epidemiology and Virulence Profiles of Colistin-Resistant Klebsiella pneumoniae Blood Isolates From the Hospital Agency "Ospedale dei Colli," Naples, Italy. Front Microbiol. 9:1463.
[11] Walter, J., Haller, S., Quinten, C., Kärki ,T., Zacher, B., Eckmanns, T., Abu Sin M, Plachouras, D., Kinross, P., and Suetens, C.(2018) Ecdc Pps Study Group Healthcare-associated pneumonia in acute care hospitals in European Union/European Economic Area countries: an analysis of data from a point prevalence survey Med J. 2(6): 1022-1027.
[12] Podshun.R. and Ullmann.(1998). Klebsiella spp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors. Clin. Microbiol. Rev. 11(4): p. 589–603.
[13] Cortes, G., Borrell, N., de Astorza, B., Gomez, C., Sauleda, J., and Alberti, S. (2002). Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect Immun 70: 2583–2590.
[14] Matatov, R., Goldhar, J., Skutelsky, E., Sechter, I., Perry, R., and Podschun, R.,. (1999) Inability of encapsulated Klebsiella pneumoniae to assemble functional type 1 fimbriae on their surface. FEMS Microbiol Lett. 179: 123–130.
[15] Sahly, H., Navon-Venezia, S.,Roesler, L., Hay, A.,Carmeli, Y., Podschun, R., Hennequin, C.,Forestier, C. and Ofek, I. (2008). Extended-spectrum betalactamase production is associated with an increase in cell invasion and expression of fimbrial adhesins in Klebsiella pneumoniae. Antimicrob Agents Chemother. 52:3029 –3034.
[16] Brisse,S and Grimont,P.A.D.(2006). The Genus Klebsiella. Prokaryotes, 6:159–196.
[17] Straus, D. C. 1987. Production of an extracellular toxic complexby various strains of Klebsiella pneumoniae. Infect. Immun. 55:44–48.
[18] Podschun, R., and Sahly, H. (1991). Hemagglutinins of Klebsiellapneumoniae and K. oxytoca isolated from different sources. Zbl. Hyg. Umweltmed. 191(1):46–52.
[19] Ofek, I., Goldhar,J, Keisari,Y. and Sharon, N. (1995). Nonopsonic phagocytosis of microorganisms. Ann. Rev. Microbiol. 49:239–276.
[20] Przondo-Hessek, A. and Pulverer, G. (1983). Hemagglutininsof Klebsiella pneumoniae and Klebsiella oxytoca. Zbl. Bakteriol. Mikrobiol. Hyg. 255(4):472–478.
[21] Lear, G., and Lewis, G.D. (2012). Microbial Biofilms: Current Research and Applications. Caister Academic Press.p: 96-97.
[22] Yung-Hua, L., Lau P.C.Y., Lee, J.H., Ellen, R.P.and Cvitkovitch, D.G. (2001).Natural genetic transformation of Streptococcus mutans growing in biofilms. J Bacteriol : 183:897–908.
[23] Dunne, W.M.(2002) .Bacterial adhesion: seen any good biofilm lately? Clin. Microbiol. Rev. 15: 155–166.
[24] Toole,G.A. and Kolter,R. (1998). Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol. Microbiol. 30, 295–304.
[25] Davies,D.G. and Geesey, G.G.(1995). Regulation of the alginate biosynthesis gene algC in Pseudomonas aeruginosa during biofilm development in continuous culture. Appl. Environ. Microbiol. 61: 860–867.
[26] Lawrence, J.R.,Korber, D.R., Hoyle, B.D., Costertion, J.W. and Caldwell, D.E.(1991). Optical sectioning of microbial biofilms. J. Bacteriol. 173: 6558–6567.
[27] Costerton, J.W., Lewandowski, Z., Caldwell, D.E.,Korber, D.R, and Lappin-Scott, H.M.(1995). Microbial biofilms. Annu. Rev. Microbiol. 49: 711–745.
[28] Stoodley, P., Sauer, K., Davies, D.G.,and Costerton, J.W.(2002). Biofilms as complex differentiated communities. Annu. Rev. Microbiol. 56: 187–209.
[29] Niveditha, S., Pramodhini, S., Umadevi, S., Kumar, S.and Stephen, S.(2012). The isolation and the biofilm formation of uropathogens in the patients with catheter associated urinary tract infections (UTIs). J. Clin. Diag. Res. 6: 1478–1482.
[30] Singhai, M., Malik, A., Shahid, M., Malik, M.A. and Goyal, R. A.(2012). study on device-related infections with special reference to biofilm production and antibiotic resistance. J. Glob. Infect. Dis. 4: 193–198.
[31] Nicolau-Korres, A.M., Aquije, G.M., Buss, D.S., Ventura, J.A., Fernandes, P.M.and Fernandes, A.A.(2013). Comparison of biofilm and attachment mechanisms of a phytopathological and clinical isolate of Klebsiella pneumoniae subsp. pneumoniae. Sci. World J. 10: 925375.
[32] Donelli, G.and Vuotto, C.(2014). Biofilm-based infections in long-term care facilities. Future Microbiol. 9: 175–188.
[33] Liu, C.and Guo, J.(2020).Characteristics of ventilator-associated pneumonia due to hypervirulent Klebsiella pneumoniae genotype in genetic background for the elderly in two tertiary hospitals in China. Antimicrob Resist Infect Control ;7:95.
[34] Mitharwal, S.M., Yaddanapudi, S., Bhardwaj, N.,Gautam, V., Biswal, M.,and Yaddanapudi, L.(2016). Intensive care unit-acquired infections in a tertiary care hospital: An epidemiologic survey and influence on patient outcomes. Am J Infect Control. 44(7): 113-7.
[35]Venkataraman, R.,Divatia, J.V.,Ramakrishnan, N.,Chawla, R., Amin, P.;Gopal, P.,Chaudhry, D., Zirpe, and K.,Abraham, B.(2018). Multicenter Observational Study to Evaluate Epidemiology and Resistance Patterns of Common Intensive Care Unit-infections. Indian J Crit Care Med. 22(1):20-26. | ||
|
Statistics Article View: 148 PDF Download: 243 |
||